STELLA PHARMA CORPORATION 4888Short Interest
Estimated short interest in STELLA PHARMA CORPORATION (4888) is 2.04% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: GOLDMAN SACHS INTERNATIONAL, Morgan Stanley MUFG Securities Co., Ltd.
Estimated short interest
2.04%
±0.00%
Estimated position (shares)
778,000
As of 2026-11-18
Holders (0.5% or more)
2 firms
1067 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 2 institutions whose last report is more than a year old (2.27% in total). It also excludes 13 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2021-06-16 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 0.81%) |
| Reporting institutions | 18 firms (1067 reports) |
| Peak estimated short interest | 7.80% (2026-04-22, 7 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- GOLDMAN SACHS INTERNATIONAL
- Morgan Stanley MUFG Securities Co., Ltd.
- Citigroup Global Markets Limited
- Nomura International plc
- JPM Securities Japan Co Ltd.
- Others
2.04%
Estimated short interest, 2026-11-18
Morgan Stanley MUFG Securities Co., Ltd.0.81%
GOLDMAN SACHS INTERNATIONAL1.23%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 469,800 shares | Ratio 1.23% | ▲0.37% | Holding |
| 2024-06-14 | Arrowstreet EAFE Alpha Extension Trust Fund | Position 383,600 shares | Ratio 1.19% | ▼0.06% | No report for 1+ year |
| 2024-08-23 | series ARROWSTREET EAFE ALPHA EXTENSION TRUST FUND A SUB FUND OF ARROWSTREET INVESTMENT TRUST | Position 369,700 shares | Ratio 1.08% | ▼0.11% | No report for 1+ year |
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 308,200 shares | Ratio 0.81% | ▲0.39% | Holding |
| 2023-08-09 | MERRILL LYNCH INTERNATIONAL | Position 153,300 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2022-04-25 | Citigroup Global Markets Limited | Position 141,200 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2022-10-14 | BNP Paribas Arbitrage SNC | Position 140,900 shares | Ratio 0.49% | ▼0.08% | Below 0.5% |
| 2026-05-19 | PDT Partners, LLC | Position 174,000 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2022-01-11 | Credit Suisse AG | Position 136,400 shares | Ratio 0.47% | ▼0.25% | Below 0.5% |
| 2026-05-27 | Barclays Bank PLC | Position 164,200 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-01-13 | UBS AG | Position 156,121 shares | Ratio 0.45% | ▼0.08% | Below 0.5% |
| 2026-04-09 | Arrowstreet Capital, Limited Partnership | Position 152,100 shares | Ratio 0.44% | ▼0.06% | Below 0.5% |
| 2026-05-15 | JPM Securities Japan Co Ltd. | Position 152,556 shares | Ratio 0.43% | ▼0.35% | Below 0.5% |
| 2022-11-21 | Arrowstreet ACWI ex US Alpha Extension Trust Fund U | Position 124,800 shares | Ratio 0.43% | ▼0.08% | Below 0.5% |
| 2026-11-10 | Nomura International plc | Position 163,700 shares | Ratio 0.43% | ▼0.07% | Below 0.5% |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 133,187 shares | Ratio 0.35% | ▼0.25% | Below 0.5% |
| 2023-01-17 | SMBC Nikko Securities Inc. | Position 5,400 shares | Ratio 0.01% | ▼0.52% | Below 0.5% |
| 2022-10-27 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼1.71% | Closed |
Disclosure History 1067 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 308,200 shares | Ratio 0.81% | ▲0.39% | — |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 469,800 shares | Ratio 1.23% | ▲0.37% | — |
| 2026-11-13 | GOLDMAN SACHS INTERNATIONAL | Position 330,300 shares | Ratio 0.86% | ▼0.11% | — |
| 2026-11-10 | Nomura International plc | Position 163,700 shares | Ratio 0.43% | ▼0.07% | Below 0.5% |
| 2026-11-10 | GOLDMAN SACHS INTERNATIONAL | Position 372,400 shares | Ratio 0.97% | ▼0.04% | — |
| 2026-11-06 | Nomura International plc | Position 191,500 shares | Ratio 0.50% | ▼0.17% | — |
| 2026-11-05 | Nomura International plc | Position 248,600 shares | Ratio 0.67% | ▲0.11% | — |
| 2026-11-05 | GOLDMAN SACHS INTERNATIONAL | Position 385,800 shares | Ratio 1.01% | ▲0.06% | — |
| 2026-11-04 | Nomura International plc | Position 210,800 shares | Ratio 0.56% | ▼0.04% | — |
| 2026-10-29 | Nomura International plc | Position 223,700 shares | Ratio 0.60% | ▲0.06% | — |
| 2026-10-28 | Nomura International plc | Position 201,300 shares | Ratio 0.54% | ▼0.15% | — |
| 2026-10-27 | Nomura International plc | Position 258,100 shares | Ratio 0.69% | ▼0.08% | — |
| 2026-10-23 | Nomura International plc | Position 288,700 shares | Ratio 0.77% | ▼0.03% | — |
| 2026-10-23 | GOLDMAN SACHS INTERNATIONAL | Position 354,900 shares | Ratio 0.95% | ▼0.08% | — |
| 2026-10-22 | GOLDMAN SACHS INTERNATIONAL | Position 384,800 shares | Ratio 1.03% | ▲0.21% | — |
| 2026-10-21 | Nomura International plc | Position 258,300 shares | Ratio 0.69% | ▼0.16% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 133,187 shares | Ratio 0.35% | ▼0.25% | Below 0.5% |
| 2026-10-19 | Barclays Capital Securities Ltd | Position 223,887 shares | Ratio 0.60% | ▼0.10% | — |
| 2026-10-16 | Nomura International plc | Position 318,300 shares | Ratio 0.85% | ▼0.13% | — |
| 2026-10-16 | GOLDMAN SACHS INTERNATIONAL | Position 305,500 shares | Ratio 0.82% | ▲0.08% | — |
| 2026-10-16 | Barclays Capital Securities Ltd | Position 259,987 shares | Ratio 0.70% | ▼0.14% | — |
| 2026-10-15 | Barclays Capital Securities Ltd | Position 313,287 shares | Ratio 0.84% | ▼0.23% | — |
| 2026-10-14 | Nomura International plc | Position 366,200 shares | Ratio 0.98% | ▼0.10% | — |
| 2026-10-14 | GOLDMAN SACHS INTERNATIONAL | Position 277,700 shares | Ratio 0.74% | ▲0.08% | — |
| 2026-10-14 | Barclays Capital Securities Ltd | Position 397,787 shares | Ratio 1.07% | ▼0.11% | — |
| 2026-10-13 | Nomura International plc | Position 402,800 shares | Ratio 1.08% | ▼0.07% | — |
| 2026-10-13 | GOLDMAN SACHS INTERNATIONAL | Position 246,500 shares | Ratio 0.66% | ▲0.15% | — |
| 2026-10-09 | GOLDMAN SACHS INTERNATIONAL | Position 192,000 shares | Ratio 0.51% | ▼0.10% | — |
| 2026-10-08 | Nomura International plc | Position 426,000 shares | Ratio 1.15% | ▲0.12% | — |
| 2026-10-08 | GOLDMAN SACHS INTERNATIONAL | Position 228,900 shares | Ratio 0.61% | ▲0.21% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Modalis Therapeutics Corporation4883 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kringle Pharma,Inc.4884 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| MUROMACHI CHEMICALS INC.4885 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ASKA Pharmaceutical Holdings Co.,Ltd.4886 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| SAWAI GROUP HOLDINGS Co.,Ltd.4887 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Renascience Inc.4889 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |